# Stem Cell Transplantation for Stiff Person Syndrome (SPS)

> **NCT02282514** · PHASE1,PHASE2 · TERMINATED · sponsor: **Northwestern University** · enrollment: 23 (actual)

## Conditions studied

- Stiff-Person Syndrome

## Interventions

- **BIOLOGICAL:** Autologous Hematopoietic Stem Cells
- **DRUG:** Cyclophosphamide
- **DRUG:** Mesna
- **DRUG:** rATG
- **DRUG:** Methylprednisolone
- **DRUG:** G-CSF
- **DRUG:** Rituxan

## Key facts

- **NCT ID:** NCT02282514
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-10
- **Primary completion:** 2019-08-19
- **Final completion:** 2019-08-30
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** Could not predict who would respond, relapse or go into remission
- **Last updated:** 2021-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02282514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02282514, "Stem Cell Transplantation for Stiff Person Syndrome (SPS)". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT02282514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*